Riverdale Capital to Buy WSPVA Bio Products International

Riverdale Capital Ltd. (Pink Sheets: RICP) announces that it has entered into an agreement to acquire WSPVA Bio Products International, LLC ("WSPVA").

The acquisition will result in 100% ownership by RICP of WSPVA, which holds an exclusive license to develop and market PVA Film in North America utilizing a patented machine technology (see dissolvingplastic.com). Riverdale believes this PVA Film will have a unique niche in the plastic industry due to its water-soluble, non-toxic and biodegradable characteristics.

What's unique about the plastic is (i) its price point is competitive with plastics currently on the market; (ii) it biodegrades quickly in compost and landfills without any additives needed; (iii) it's stable even under extreme heat and other conditions; (iv) it's non-toxic and water-soluble and will dissolve under certain water temperatures; (v) the quality of the production process has been ISO 9001 certified; (vi) PVA has been evaluated by the FDA as "Generally Considered as Safe", and (vii) RICP will have no known PVA competitors.

Carl Kruse, the Company's President, stated, "The proposed acquisition gives RICP a unique position in the green-technology arena of North America and provides an exciting platform for growth in the green-friendly clean-products markets. It will enable the Company to compete directly with plastic producers and/or license the technology to existing manufacturers of plastic products throughout North America. Riverdale anticipates many possible new and innovative uses for this new product."

Source: http://www.riverdalecapital.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.